Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Merja Lindfors"'
Autor:
Eveliina Tarkka, Heli Piiparinen, Minna Mäki, Sanna Laakso, C Carder, Laura E. Savolainen, Päivi Tissari, Sointu Mero, Alimuddin Zumla, Martti Vaara, Anne Aittakorpi, Vanya Gant, Merja Lindfors, Jim F. Huggett
Publikováno v:
The Lancet. 375:224-230
Summary Background New DNA-based microarray platforms enable rapid detection and species identification of many pathogens, including bacteria. We assessed the sensitivity, specificity, and turnaround time of a new molecular sepsis assay. Methods 2107
Autor:
Heli Piiparinen, Merja Lindfors, Sanna Laakso, Laura Huopaniemi, Pasi Piiparinen, Anne Aittakorpi, Minna Mäki, Anna-Kaarina Järvinen
Publikováno v:
BMC Microbiology, Vol 9, Iss 1, p 161 (2009)
BMC Microbiology
BMC Microbiology
Background During the course of a bacterial infection, the rapid identification of the causative agent(s) is necessary for the determination of effective treatment options. We have developed a method based on a modified broad-range PCR and an oligonu
Autor:
Laura E. Savolainen, Vanya Gant, N Kumlin, Sointu Mero, Martti Vaara, Minna Mäki, Päivi Tissari, Eveliina Tarkka, Anne Aittakorpi, Jim F. Huggett, Pasi Piiparinen, Heli Piiparinen, Sanna Laakso, C Carder, Merja Lindfors, Alimuddin Zumla
Publikováno v:
Critical Care
Europe PubMed Central
Europe PubMed Central
The Prove-it™ Sepsis assay is a rapid, broad-range PCR and microarray-based assay designed to identify the majority of sepsis-causing bacteria from positive blood cultures. The pathogen panel covers 50 Gram-negative and Gram-positive bacterial spec
Autor:
Minna Mäki, Sanna Laakso, Anne Aittakorpi, Heli Piiparinen, Laura Huopaniemi, Anna-Kaarina Järvinen, Pasi Piiparinen, Merja Lindfors
Publikováno v:
Critical Care